<DOC>
	<DOCNO>NCT00002458</DOCNO>
	<brief_summary>RATIONALE : Monoclonal antibody locate tumor cell either kill deliver tumor-killing substance without harm normal cell . PURPOSE : Phase II trial study effectiveness monoclonal antibody treat child metastatic neuroblastoma second remission .</brief_summary>
	<brief_title>Monoclonal Antibody Therapy Treating Children With Metastatic Neuroblastoma Second Remission</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate efficacy ganglioside GD2-specific monoclonal antibody 3F8 adjuvant therapy patient Stage IV neuroblastoma second remission . OUTLINE : Biological Response Modifier Therapy . Antiganglioside GD2-specific Monoclonal Antibody 3F8 , MOAB 3F8 . PROJECTED ACCRUAL : A maximum 20 patient enter .</detailed_description>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm , Stage IV neuroblastoma second subsequent complete remission , define complete disappearance evidence tumor follow : Physical examination Secondlook surgery Bone scan Bone marrow aspiration biopsy Chest xray CT MIBG Urinary catecholamine If marrow infiltrate tumor , complete elimination tumor cell marrow compartment must demonstrate histology immunofluorescence ( base simultaneous bone marrow aspiration biopsy sample least 4 separate site ) PATIENT CHARACTERISTICS : Age : Under 18 Performance status : Not specify Life expectancy : Greater 12 week Hematopoietic : Grade 4 cytopenia allow Grade 3 marrow hypoplasia allow Hepatic : Not specify Renal : No renal dysfunction bad grade 3 Cardiovascular : No cardiac dysfunction bad grade 2 Pulmonary : No pulmonary dysfunction bad grade 2 Other : No neurologic dysfunction bad grade 2 Hearing deficit allow PRIOR CONCURRENT THERAPY : Prior murine antibody therapy allow provided circulating HAMA titer le 1,000 U/mL serum ELISA</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>disseminate neuroblastoma</keyword>
	<keyword>recurrent neuroblastoma</keyword>
</DOC>